Changing diagnostic criteria for gestational diabetes in Sweden - a stepped wedge national cluster randomised controlled trial - the CDC4G study protocol

• Egile Nagusiak: Helena Fadl (Egilea), Maryam Saeedi (Egilea), Scott Montgomery (Egilea), Anders Magnuson (Egilea), Erik Schwarcz (Egilea), Kerstin Berntorp (Egilea), Verena Sengpiel (Egilea), Elisabeth Storck-Lindholm (Egilea), Helena Strevens (Egilea), Anna-Karin Wikström (Egilea), Sophia Brismar-Wendel (Egilea), Martina Persson (Egilea), Stefan Jansson (Egilea), Fredrik Ahlsson (Egilea), Carina Ursing (Egilea), Linda Ryen (Egilea), Kerstin Petersson (Egilea), Ulla-Britt Wennerholm (Egilea), Karin Hildén (Egilea), David Simmons (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The optimal criteria to diagnose gestational diabetes mellitus (GDM) remain contested. The Swedish National Board of Health introduced the 2013 WHO criteria in 2015 as a recommendation for initiation of treatment for hyperglycaemia during pregnancy. With variation in GDM screenin...